|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 January 2003 | Volume 138 Issue 2 | Pages 128-134
Congenital causes of venous thrombosis have gained increasing prominence with the description of the factor V Leiden mutation and the prothrombin gene mutation. More recently, the description of the association between increased levels of coagulation factors and venous thrombosis and the finding that patients with thrombophilia can harbor more than one prothrombotic state have further increased the clinical relevance of the congenital thrombophilic states. In this qualitative review, we summarize current knowledge of the congenital prothrombotic states and propose a simple classification system that divides the states into two broad groups: those associated with reduced levels of the inhibitors of the coagulation cascade and those associated with increased levels or function of the coagulation factors. The first group is less common than the second, but it is associated with a much higher risk for venous thrombosis. This review provides clinicians with an evidence-based, practical guide to the congenital prothrombotic states.
Author and Article Information
From St. Joseph's Hospital and McMaster University Medical Centre, Hamilton, Ontario, Canada.
Grant Support: Some of the studies cited in this report were funded by research grants from the Heart and Stroke Foundation of Ontario. Dr. Crowther holds a Canadian Institute of Health Research Scholarship. Dr. Kelton holds a Canada Research Chair.
Requests for Single Reprints: Mark A Crowther, MD, St. Joseph's Hospital, Room L208, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada.
Current Author Addresses: Dr. Crowther: St. Joseph's Hospital, Room L208, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada.
Dr. Kelton: McMaster University Medical Centre, Room 3W10, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada. REVIEW
Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
Preventing recurrent venous thromboembolism DTB, April 1, 2009; 47(4): 38 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Dalen Venous Thromboembolism and the Archives of Internal Medicine, 1908 to 2005 Arch Intern Med, January 14, 2008; 168(1): 14 - 15. [Full Text] [PDF] |
||||
![]() |
R. L. Silverstein, K. A. Bauer, M. Cushman, C. T. Esmon, W. B. Ershler, and R. P. Tracy Venous thrombosis in the elderly: more questions than answers Blood, November 1, 2007; 110(9): 3097 - 3101. [Full Text] [PDF] |
||||
![]() |
M. E. Stone, S. H. Silverman, and K. Nomoto Intracardiac Thrombosis and Acute Right Ventricular Failure Following Complex Reoperative Cardiac Surgery With Aprotinin and Deep Hypothermic Circulatory Arrest Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2007; 11(3): 177 - 184. [Abstract] [PDF] |
||||
![]() |
A. Marchiori, L. Mosena, M. H. Prins, and P. Prandoni The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies Haematologica, August 1, 2007; 92(8): 1107 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Austin, H. Cohen, and N. Losseff Haematology and neurology J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 334 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D Blann and G. Y H Lip Venous thromboembolism BMJ, January 28, 2006; 332(7535): 215 - 219. [Full Text] [PDF] |
||||
![]() |
M. J. Beck and B. Berman Review of Thrombophilic States Clinical Pediatrics, April 1, 2005; 44(3): 193 - 199. [PDF] |
||||
![]() |
G. A. Knoll, P. S. Wells, D. Young, S. L. Perkins, R. M. Pilkey, J. J. Clinch, and M. A. Rodger Thrombophilia and the Risk for Hemodialysis Vascular Access Thrombosis J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1108 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ginsburg Genetic Risk Factors for Arterial Thrombosis and Inflammation Hematology, January 1, 2005; 2005(1): 442 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cushman Inherited Risk Factors for Venous Thrombosis Hematology, January 1, 2005; 2005(1): 452 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Buller, G. Agnelli, R. D. Hull, T. M. Hyers, M. H. Prins, and G. E. Raskob Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 401S - 428S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Donahue Factor V Leiden and Perioperative Risk Anesth. Analg., June 1, 2004; 98(6): 1623 - 1634. [Abstract] [Full Text] [PDF] |
||||